363 related articles for article (PubMed ID: 30404656)
1. Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis.
Zubiri I; Lombardi V; Bremang M; Mitra V; Nardo G; Adiutori R; Lu CH; Leoni E; Yip P; Yildiz O; Ward M; Greensmith L; Bendotti C; Pike I; Malaspina A
Mol Neurodegener; 2018 Nov; 13(1):60. PubMed ID: 30404656
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach.
Zhou JY; Afjehi-Sadat L; Asress S; Duong DM; Cudkowicz M; Glass JD; Peng J
J Proteome Res; 2010 Oct; 9(10):5133-41. PubMed ID: 20698585
[TBL] [Abstract][Full Text] [Related]
3. Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis.
Leoni E; Bremang M; Mitra V; Zubiri I; Jung S; Lu CH; Adiutori R; Lombardi V; Russell C; Koncarevic S; Ward M; Pike I; Malaspina A
Sci Rep; 2019 Mar; 9(1):4478. PubMed ID: 30872628
[TBL] [Abstract][Full Text] [Related]
4. Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral Sclerosis.
Moreno-Martínez L; de la Torre M; Toivonen JM; Zaragoza P; García-Redondo A; Calvo AC; Osta R
Front Immunol; 2019; 10():801. PubMed ID: 31031774
[No Abstract] [Full Text] [Related]
5. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
Ng SK; Higashimori H; Tolman M; Yang Y
Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
[TBL] [Abstract][Full Text] [Related]
6. Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells.
Nardo G; Pozzi S; Pignataro M; Lauranzano E; Spano G; Garbelli S; Mantovani S; Marinou K; Papetti L; Monteforte M; Torri V; Paris L; Bazzoni G; Lunetta C; Corbo M; Mora G; Bendotti C; Bonetto V
PLoS One; 2011; 6(10):e25545. PubMed ID: 21998667
[TBL] [Abstract][Full Text] [Related]
7. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis.
Kudo LC; Parfenova L; Vi N; Lau K; Pomakian J; Valdmanis P; Rouleau GA; Vinters HV; Wiedau-Pazos M; Karsten SL
Hum Mol Genet; 2010 Aug; 19(16):3233-53. PubMed ID: 20530642
[TBL] [Abstract][Full Text] [Related]
8. Plasma oxylipin profiling by high resolution mass spectrometry reveal signatures of inflammation and hypermetabolism in amyotrophic lateral sclerosis.
Chaves-Filho AB; Diniz LS; Santos RS; Lima RS; Oreliana H; Pinto IFD; Dantas LS; Inague A; Faria RL; Medeiros MHG; Glezer I; Festuccia WT; Yoshinaga MY; Miyamoto S
Free Radic Biol Med; 2023 Nov; 208():285-298. PubMed ID: 37619957
[TBL] [Abstract][Full Text] [Related]
9. Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord.
Zhai J; Ström AL; Kilty R; Venkatakrishnan P; White J; Everson WV; Smart EJ; Zhu H
FEBS J; 2009 Jun; 276(12):3308-23. PubMed ID: 19438725
[TBL] [Abstract][Full Text] [Related]
10. Heat shock factor 1 over-expression protects against exposure of hydrophobic residues on mutant SOD1 and early mortality in a mouse model of amyotrophic lateral sclerosis.
Lin PY; Simon SM; Koh WK; Folorunso O; Umbaugh CS; Pierce A
Mol Neurodegener; 2013 Nov; 8():43. PubMed ID: 24256636
[TBL] [Abstract][Full Text] [Related]
11. Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS.
Lu CH; Petzold A; Kalmar B; Dick J; Malaspina A; Greensmith L
PLoS One; 2012; 7(7):e40998. PubMed ID: 22815892
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis.
Pansarasa O; Garofalo M; Scarian E; Dragoni F; Garau J; Di Gerlando R; Diamanti L; Bordoni M; Gagliardi S
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269723
[TBL] [Abstract][Full Text] [Related]
13. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
[TBL] [Abstract][Full Text] [Related]
14. Senescent-like Blood Lymphocytes and Disease Progression in Amyotrophic Lateral Sclerosis.
Yildiz O; Schroth J; Tree T; Turner MR; Shaw PJ; Henson SM; Malaspina A
Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36323511
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis.
Toivonen JM; Manzano R; Oliván S; Zaragoza P; García-Redondo A; Osta R
PLoS One; 2014; 9(2):e89065. PubMed ID: 24586506
[TBL] [Abstract][Full Text] [Related]
16. Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis.
Marino M; Papa S; Crippa V; Nardo G; Peviani M; Cheroni C; Trolese MC; Lauranzano E; Bonetto V; Poletti A; DeBiasi S; Ferraiuolo L; Shaw PJ; Bendotti C
Neurobiol Aging; 2015 Jan; 36(1):492-504. PubMed ID: 25085783
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
[TBL] [Abstract][Full Text] [Related]
18. Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.
Sheean RK; McKay FC; Cretney E; Bye CR; Perera ND; Tomas D; Weston RA; Scheller KJ; Djouma E; Menon P; Schibeci SD; Marmash N; Yerbury JJ; Nutt SL; Booth DR; Stewart GJ; Kiernan MC; Vucic S; Turner BJ
JAMA Neurol; 2018 Jun; 75(6):681-689. PubMed ID: 29507931
[TBL] [Abstract][Full Text] [Related]
19. Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis.
Si Y; Cui X; Crossman DK; Hao J; Kazamel M; Kwon Y; King PH
Neurobiol Dis; 2018 Jun; 114():85-94. PubMed ID: 29486297
[TBL] [Abstract][Full Text] [Related]
20. Immune response in peripheral axons delays disease progression in SOD1
Nardo G; Trolese MC; de Vito G; Cecchi R; Riva N; Dina G; Heath PR; Quattrini A; Shaw PJ; Piazza V; Bendotti C
J Neuroinflammation; 2016 Oct; 13(1):261. PubMed ID: 27717377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
